In the in vivo experiments, DCM mice that were treated with AAV-cTnT-shRNA-Ppp2r5d exhibited severe cardiac dysfunction, ventricular fibrosis, and ventricular dilatation compared to the control group. The gene discussed is TNNT2; the disease is Ventriculomegaly.